Psychoeducational Multifamily Groups Intervention Summary

Psychoeducational Multifamily Groups (PMFG) is a treatment modality designed to help individuals with mental illness attain as rich and full participation in the usual life of the community as possible. The intervention focuses on informing families and support people about mental illness, developing coping skills, solving problems, creating social supports, and developing an alliance between consumers, practitioners, and their families or other support people. Practitioners invite five to six consumers and their families to participate in a psychoeducation group that typically meets every other week for at least 6 months. "Family" is defined as anyone committed to the care and support of the person with mental illness. Consumers often ask a close friend or neighbor to be their support person in the group. Group meetings are structured to help people develop the skills needed to handle problems posed by mental illness.

Descriptive Information

Areas of Interest Mental health treatment
Outcomes Review Date: December 2006
1: Employment among persons who have schizophrenia
2: Psychiatric relapse
3: Symptoms of schizophrenia
4: Family stress
Outcome Categories Employment
Family/relationships
Mental health
Treatment/recovery
Ages 18-25 (Young adult)
26-55 (Adult)
Genders Male
Female
Races/Ethnicities Asian
Black or African American
Hispanic or Latino
White
Race/ethnicity unspecified
Settings Outpatient
Other community settings
Geographic Locations Urban
Suburban
Implementation History Psychoeducational multifamily groups have been implemented in many States including California, Maryland, Maine, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New York, Oregon, Washington, and Vermont. Internationally, the intervention has been used in Australia, Canada, China, Denmark, Germany, Italy, Japan, Kosovo, the Netherlands, Norway, Spain, Switzerland, and the United Kingdom. It is estimated that several thousand sites are presently using PMFG, not including applications to other psychiatric or psychosocial disorders. Tens of thousands of consumers have participated in these multifamily groups.
NIH Funding/CER Studies Partially/fully funded by National Institutes of Health: Yes
Evaluated in comparative effectiveness research studies: Yes
Adaptations PMFG treatment has been adapted and evaluated internationally and with various populations, including persons diagnosed with depression, borderline personality disorder, Alzheimer's disease, conduct disorders (in children), and affective disorders. It has also been implemented with cancer survivors.
Adverse Effects No adverse effects, concerns, or unintended consequences were identified by the developer.
IOM Prevention Categories IOM prevention categories are not applicable.